Skip to main content
. 2024 Sep 18;14(9):1170. doi: 10.3390/biom14091170

Table 4.

Cytotoxicity activities (IC50) of AgNPs against hepatocellular cancer (HepG-2) and breast cancer cells (MCF-7).

Cell Lines IC50 µg/mL
AgNPs Doxorubicin
HepG2 7.6 5.07
MCF-7 35.4 5.24